We heard about multiple deals in the works, but that would be strange given all the time, that has past, with no announcement. One Company may want to stay quiet, but getting three, at least that's the number we heard, to remain silent, would be a tough thing to pull off. I thought Bayer would be the one to do it when they were in play, as they had all the competing product line in their portfolio. They have chronic pain products, Menstrual Pain products, and the Dr Scholls angle, which they no longer have, plus they have an Animal Health and Wellness Division. I thought it was a perfect fit, for a total revamping from only having the drug angle. A one Company fits all would be the way to fully take advantage of product expansion, thus keeping it away from competitors. We see all the different Companies using Ten's products in product expanding. IMO it doesn't give a Company any advantage in having others duplicate your new product expansion, JMHO. The "total silence on anything Company related, is the curious factor. Who knows, what's going on, I certainly don't, just guessing, as there is nothing else too do. JMHO Have a great day.
News 
Market Data 
Discover 
